Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The 340B Drug Pricing Program (the "Program") allows certain healthcare providers ("covered entities") to purchase pharmaceuticals from drug manufacturers at discounted rates.
The U.S. Supreme Court ruled in July that the Department of Health and Human Services illegally cut drug reimbursement under its 340B discount drug program. The agency slashed reimbursement for hospitals receiving 304B discounts by nearly 30% in 2018.
Hospitals that exploit the federal 340B Drug Pricing Program by double-billing for their profit are doing so to the detriment of the program and endangering needy patients.
It has been two years since President Biden signed a far-reaching, industry-spanning Executive Order on Promoting Competition in the American Economy. The Executive Order outlined a...
Each year, maintaining patient access to affordable and quality health care becomes more and more difficult as rural hospitals face an uncertain financial future. Across rural America, hospitals are closing their doors at an alarming rate, with 152 rural hospitals closing since 2010. What's more, 19 of these closures occurred in 2020 alone, the most of any year in the past decade.